FDA Will Consider Nano-Ingredients At An October Meeting
This article was originally published in The Gray Sheet
Executive Summary
Medical products manufactured using materials that can be measured and controlled at dimensions one thousand- to one hundred thousand-times smaller than the thickness of a sheet of paper will be the subject of a public meeting FDA is planning for mid-October